It doesn't get much press nor do I see many expressing optimize on it. I don't have the science background of many posters here so my opinion on the matter is based on superficial understanding of immunoglobulin but I would think it has better odds than most people think. There is actually quite a lot in pubmed on it, its not a pure shot in the dark. I am not saying the trials have 50-75% odds of success nor am I expecting dramatic improvement but I wouldn't be shocked to see at least one of the trials show statistical significance.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.